๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
SRT2104 is a potent small molecule activator of SIRT1 that has been found t...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-12-09
Trial ID
NCT01014117
The primary purpose of this study is to evaluate the safety and tolerabilit...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-05-28
Trial ID
NCT01031108
The primary objective of this study is to assess the pharmacokinetic profil...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-01-20
Trial ID
NCT00938275
Treatments Being Tested
The purpose of this research study is to: * 1\) Test the safety and tolera...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-02-13
Trial ID
NCT01453491
Treatments Being Tested
The primary objective is to determine the pharmacokinetics, safety and tole...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-10-01
Trial ID
NCT00964340
This is an open-label, randomized, controlled, single center study to asses...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-10-30
Trial ID
NCT01702493
Randomized, placebo-controlled, parallel-group, double-blind, multiple-dose...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-03-03
Trial ID
NCT01018017
This double-blind, placebo-controlled study will be conducted at 5 study ce...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-06-07
Trial ID
NCT01154101
The main purpose of this study is to investigate the effect of SRT2104 upon...
Status
Withdrawn
Location
Multiple Locations
Start Date
2011-01
Trial ID
NCT01039909
The purpose of this study is to assess the pharmacokinetic profile, safety,...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-03-23
Trial ID
NCT00933062